Wolff–Parkinson–White syndrome: Difference between revisions
No edit summary |
|||
| Line 1: | Line 1: | ||
==Background== | ==Background== | ||
*Suspect in any pt w/ ventricular rate >300 | |||
===Types=== | |||
*Orthodromic (~95%) | *Orthodromic (~95%) | ||
**Accessory pathway (Kent bundles) is used for retrograde reentry conduction | **Accessory pathway (Kent bundles) is used for retrograde reentry conduction | ||
| Line 8: | Line 11: | ||
**Accessory pathway used for anterograde conduction | **Accessory pathway used for anterograde conduction | ||
***QRS wide, delta wave present | ***QRS wide, delta wave present | ||
==Diagnosis== | ==Diagnosis== | ||
| Line 24: | Line 24: | ||
==Treatment== | ==Treatment== | ||
*Orthodromic | *Orthodromic | ||
**Treat like paroxysmal SVT | **Treat like paroxysmal SVT: | ||
*** | ***Unstable | ||
*** | ****Cardioversion (synchronized) | ||
* | *****Adult: 50-100 J | ||
***Adult: 50-100 J | *****Peds: 0.5-2 J/kg | ||
***Peds: 0.5- 2 J/kg | ***Stable | ||
****CCBs, BBs, procainamide, or adenosine | |||
*****Procainamide safe irrespective of type of pathway conduction | |||
*Antidromic | *Antidromic | ||
**Treat like ventricular tachycardia | **Treat like ventricular tachycardia: | ||
***Cardioversion (synchronized) | |||
****Adult: 50-100 J | |||
****Peds: 0.5-2 J/kg | |||
***Procainamide | |||
****17mg/kg IV over 30min up to 50mg/kg or 50% widening of QRS complex | |||
***Amiodarone | |||
***Contraindicated: CCBs, BBs, digoxin, adenosine | ***Contraindicated: CCBs, BBs, digoxin, adenosine | ||
==Disposition== | ==Disposition== | ||
Revision as of 04:57, 26 March 2012
Background
- Suspect in any pt w/ ventricular rate >300
Types
- Orthodromic (~95%)
- Accessory pathway (Kent bundles) is used for retrograde reentry conduction
- QRS narrow (delta wave absent)
- May see ST depression, TWI
- Rate 150-250 bpm
- Accessory pathway (Kent bundles) is used for retrograde reentry conduction
- Antidromic (~5%)
- Accessory pathway used for anterograde conduction
- QRS wide, delta wave present
- Accessory pathway used for anterograde conduction
Diagnosis
- Characteristic features not always seen on ECG
- Short PR interval - <0.12sec
- Due to loss of normal AV node conduction delay
- Delta wave / slurred upstroke
- Due to early activation of ventricular myocardium
- QRS duration > 0.10 sec
- Due to delta wave
Treatment
- Orthodromic
- Treat like paroxysmal SVT:
- Unstable
- Cardioversion (synchronized)
- Adult: 50-100 J
- Peds: 0.5-2 J/kg
- Cardioversion (synchronized)
- Stable
- CCBs, BBs, procainamide, or adenosine
- Procainamide safe irrespective of type of pathway conduction
- CCBs, BBs, procainamide, or adenosine
- Unstable
- Treat like paroxysmal SVT:
- Antidromic
- Treat like ventricular tachycardia:
- Cardioversion (synchronized)
- Adult: 50-100 J
- Peds: 0.5-2 J/kg
- Procainamide
- 17mg/kg IV over 30min up to 50mg/kg or 50% widening of QRS complex
- Amiodarone
- Contraindicated: CCBs, BBs, digoxin, adenosine
- Cardioversion (synchronized)
- Treat like ventricular tachycardia:
Disposition
- Admit:
- Pts with chest pain, CHF, electrolyte imbalance, or required cardioversion
- Discharge:
- Consider if dysrhythmia was easily terminated and can arrange outpt EP study
